Literature DB >> 12077063

A role for inflammation in irritable bowel syndrome?

G Barbara1, R De Giorgio, V Stanghellini, C Cremon, R Corinaldesi.   

Abstract

Attention has been directed to the putative role of low grade mucosal inflammation in irritable bowel syndrome (IBS) on the basis of evidence showing that some patients with IBS have an increased number of inflammatory cells in the colonic and ileal mucosa. Previous episodes of infectious enteritis, genetic factors, undiagnosed food allergies, and changes in bacterial microflora may all play a role in promoting and perpetuating this low grade inflammatory process. Human and animal studies support the concept that inflammation may perturb gastrointestinal reflexes and activate the visceral sensory system even when the inflammatory response is minimal and confined to the mucosa. Thus abnormal neuroimmune interactions may contribute to the altered gastrointestinal physiology and hypersensitivity that underlies IBS. A brief review of the human and animal studies that have focused on the putative role of intestinal inflammation and infections in the pathogenesis of IBS is given.

Entities:  

Mesh:

Year:  2002        PMID: 12077063      PMCID: PMC1867730          DOI: 10.1136/gut.51.suppl_1.i41

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  Probiotics: could they turn out to be ineffective in irritable bowel syndrome?

Authors:  G Barbara; R Corinaldesi
Journal:  Dig Liver Dis       Date:  2000-05       Impact factor: 4.088

2.  Mast cells in inflammatory conditions of the gastrointestinal tract.

Authors:  R B HIATT; L KATZ
Journal:  Am J Gastroenterol       Date:  1962-05       Impact factor: 10.864

3.  Sigmoid afferent mechanisms in patients with irritable bowel syndrome.

Authors:  T Lembo; J Munakata; B Naliboff; S Fullerton; E A Mayer
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

4.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

5.  Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects.

Authors:  A Prior; D G Maxton; P J Whorwell
Journal:  Gut       Date:  1990-04       Impact factor: 23.059

6.  Terminal ileal mucosal mast cells in irritable bowel syndrome.

Authors:  A P Weston; W L Biddle; P S Bhatia; P B Miner
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

7.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

8.  Psychometric scores and persistence of irritable bowel after infectious diarrhoea.

Authors:  K A Gwee; J C Graham; M W McKendrick; S M Collins; J S Marshall; S J Walters; N W Read
Journal:  Lancet       Date:  1996-01-20       Impact factor: 79.321

9.  Antigen-induced contraction of jejunal smooth muscle in the sensitized rat.

Authors:  D L Vermillion; P B Ernst; R Scicchitano; S M Collins
Journal:  Am J Physiol       Date:  1988-12

10.  Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice.

Authors:  B K Wershil; G T Furuta; Z S Wang; S J Galli
Journal:  Gastroenterology       Date:  1996-05       Impact factor: 22.682

View more
  81 in total

Review 1.  Clinical metabolomics paves the way towards future healthcare strategies.

Authors:  Sebastiano Collino; François-Pierre J Martin; Serge Rezzi
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

2.  Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study.

Authors:  A Y Del Valle-Pinero; A C Martino; T J Taylor; B L Majors; N S Patel; M M Heitkemper; W A Henderson
Journal:  Neurogastroenterol Motil       Date:  2011-09-23       Impact factor: 3.598

3.  Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease.

Authors:  Antonio Colecchia; Amanda Vestito; Francesca Pasqui; Giuseppe Mazzella; Enrico Roda; Francesca Pistoia; Giovanni Brandimarte; Davide Festi
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

Review 4.  New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond.

Authors:  Emanuele Sinagra; Gaetano Cristian Morreale; Ghazaleh Mohammadian; Giorgio Fusco; Valentina Guarnotta; Giovanni Tomasello; Francesco Cappello; Francesca Rossi; Georgios Amvrosiadis; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2017-09-28       Impact factor: 5.742

5.  High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.

Authors:  Keren Hod; Tamar Ringel-Kulka; Christopher F Martin; Nitsan Maharshak; Yehuda Ringel
Journal:  J Clin Gastroenterol       Date:  2016-03       Impact factor: 3.062

6.  Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis.

Authors:  Ji Yong Ahn; Kyung Hun Lee; Chang Hwan Choi; Ju Wan Kim; Hyun Woong Lee; Jeong Wook Kim; Mi Kyung Kim; Gui Young Kwon; Seungbong Han; Seong-Eun Kim; Sung Min Kim; Sae Kyung Chang
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

7.  The endogenous cannabinoid system protects against colonic inflammation.

Authors:  Federico Massa; Giovanni Marsicano; Heike Hermann; Astrid Cannich; Krisztina Monory; Benjamin F Cravatt; Gian-Luca Ferri; Andrei Sibaev; Martin Storr; Beat Lutz
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Structural changes in the epithelium of the small intestine and immune cell infiltration of enteric ganglia following acute mucosal damage and local inflammation.

Authors:  Louise Pontell; Patricia Castelucci; Mária Bagyánszki; Tanja Jovic; Michelle Thacker; Kulmira Nurgali; Romke Bron; John B Furness
Journal:  Virchows Arch       Date:  2009-06-11       Impact factor: 4.064

9.  Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats.

Authors:  Jun-Ho La; Tae-Sik Sung; Hyun-Ju Kim; Tae-Wan Kim; Tong-Mook Kang; Il-Suk Yang
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 10.  New insights into the psychosocial aspects of irritable bowel syndrome.

Authors:  Richard Lea; Peter J Whorwell
Journal:  Curr Gastroenterol Rep       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.